2 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow TG-0054: new trials by email Literature Review of TG-0054 trials Research Report on TG-0054
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease TG-0054 - Multiple Myeloma, Non-hodgkin's Lymphoma | Phase 2 | Completed | GPCR Therapeutics, Inc. | 12 | 2012-10-01 | 2021-04-19 |
| Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of TG-0054 With Single IV Doses Escalation in Healthy Volunteers TG-0054 - Healthy | Phase 1 | Completed | GPCR Therapeutics, Inc. | 64 | 2008-04-01 | 2021-08-04 |
Hodgkin Disease (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1)
United States (2)
Michael W. Schuster, M.D. (1) · Ronald Goldwater, M.D. (1)